Andreas Hallqvist

6PUBLICATIONS
14CO-AUTHORS
Radiation therapyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 17, 2024
Assessment of radiation pneumonitis and predictive factors in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy.

Kerstin Gunnarsson, Louise Mövik, Niclas Pettersson

|Mar 13, 2024
Pulmonary Adenocarcinoma In Situ and Minimally Invasive Adenocarcinomas in European Patients Have Less KRAS and More EGFR Mutations Compared to Advanced Adenocarcinomas.

Jennie Petterson, Dyar Mustafa, Sashidar Bandaru

|Feb 12, 2024
Immune checkpoint blockade improves the activation and function of circulating mucosal-associated invariant T (MAIT) cells in patients with non-small cell lung cancer.

Patrik Sundström, Nikita Dutta, William Rodin

|May 27, 2022
Successful Treatment with Selpercatinib for Ectopic Cushing's Syndrome Due to Medullary Thyroid Cancer.

Oskar Ragnarsson, Marta Piasecka, Andreas Hallqvist

|May 14, 2022
KRAS Mutations Impact Clinical Outcome in Metastatic Non-Small Cell Lung Cancer.

Ella A Eklund, Clotilde Wiel, Henrik Fagman

|Nov 27, 2021
Optimizing the Schedule of PARP Inhibitors in Combination with 177Lu-DOTATATE: A Dosimetry Rationale.

Andreas Hallqvist, Johanna Svensson, Linn Hagmarker

Pageof 1

Frequent Collaborators

2 joint publications

Ella Äng Eklund

2 joint publications

Levent M Akyürek

2 joint publications

Volkan I Sayin

1 joint publications

Jean-Mathieu Beauregard